Ezrin assay method for the in vitro diagnosis of colorectal cancer
US9890196B2 · kind B2 · utility
0Cited by
8References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 12, 2012 |
| Grant date | Feb 13, 2018 |
| Priority date | — |
| Expiry date | Dec 12, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/705
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A method for the in vitro diagnosis of colorectal cancer by determining the presence of the Ezrin tumor marker in a biological sample taken from a patient suspected of having colorectal cancer using at least one anti-Ezrin monoclonal antibody directed against an Ezrin epitope chosen from the epitopes of sequence SEQ ID No.1, SEQ ID No.2, SEQ ID No.3, SEQ ID No.4+SEQ ID No.5, SEQ ID No.6+SEQ ID No.7 and SEQ ID No.8. Said method can be used for early diagnosis, screening, therapeutic follow-up and prognosis, and also for relapse diagnosis in relation to colorectal cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.